Workers’ Comp Medical Prices Vary Dramatically by State, With Fee Schedules Proving Key to Cost Control

Why It Matters

Fee schedules prove to be a powerful lever for containing workers’ compensation medical costs, directly affecting employer premiums and state budget pressures. The data highlights how policy choices can either exacerbate or mitigate inflationary pressures in a high‑risk insurance market.

Key Takeaways

• States without fee schedules pay 41%‑188% more than median
• Wisconsin prices nearly four times Massachusetts in 2025
• Florida’s fee schedule hike raised prices 41% in one year
• Non‑fee schedule states saw 2.1% annual growth vs 1.0% fee states (2008‑2025)
• Higher in‑network provider share slowed price spikes in fee‑schedule states

Pulse Analysis

Workers’ compensation medical costs have long been a hidden driver of employer insurance expenses, but the latest WCRI Medical Price Index makes the disparity unmistakable. By comparing 36 states that cover roughly 88% of U.S. workers’ comp benefits, the study finds that states without a statutory fee schedule routinely pay substantially higher rates—up to nearly double the median. This pricing gap is not merely a snapshot; it reflects a cumulative trend where non‑fee‑schedule states have seen price growth more than double that of their regulated counterparts over the past 18 years. The data underscores the importance of systematic rate setting as a cost‑control mechanism, especially for large employers and state risk pools seeking predictability.

The surge in price growth between 2021 and 2024 aligns with broader macroeconomic inflation and a pivotal shift in Medicare’s evaluation and management coding. States that tie fee‑schedule updates to general price indices inadvertently transmitted higher inflation into workers’ comp reimbursements, while those using medical‑specific indices fared better. Moreover, the CMS changes to RVU values amplified the effect, as many states base their fee schedules on Medicare benchmarks. This confluence of factors explains why non‑fee‑schedule states, which often lack the infrastructure to quickly adjust rates, experienced sharper price escalations.

Florida’s 2025 fee‑schedule overhaul offers a real‑time case study of policy impact. By raising physician reimbursement caps from 110% to 175% of Medicare, the state saw a 41% jump in overall professional‑service prices within a single year, propelling it from the bottom to near‑median rankings. The episode illustrates both the power and the risk of aggressive fee‑schedule adjustments. For policymakers, the takeaway is clear: calibrated fee schedules, coupled with robust in‑network provider participation, can temper cost growth without sacrificing access to care. Employers and insurers should monitor state‑level fee‑schedule reforms as a leading indicator of future premium trajectories.